VINCENT MILANO
CIK 1187159 · PRESIDENT AND CEO · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$994.3K
Companies
7
Total Filings
96
Lifetime Open-Market Net
-$2.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 28,896 | $4.32 | $124.8K | $0 | 9 | 2026-06-08 |
| BCRX | Director | 93,189 | $8.70 | $810.7K | $185.2K | 23 | 2026-06-02 |
| Aceragen, Inc. (ACGN) Delisted | Director | 8,987 | $0.38 | $3.4K | -$1.8K | 1 | 2023-08-11 |
| Aceragen, Inc. (IDRA) Delisted | PRESIDENT AND CEO | 208,611 | $7.22 | $1.51M | $781.5K | 22 | 2022-07-07 |
| Spark Therapeutics, Inc. (ONCE) Delisted | Director | 0 | — | — | $0 | 5 | 2019-12-17 |
| VNDA | Director | 10,000 | $5.87 | $58.7K | $0 | 9 | 2018-06-15 |
| VIROPHARMA INC (VPHM) Delisted | President and CEO | 450,898 | — | — | -$3.75M | 25 | 2014-01-21 |
Recent Filings · Page 7 of 10
96 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-08 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-22 | VNDA | Grant (A) | — | $0 | EDGAR |
| 2014-12-15 | Aceragen, Inc. (IDRA) Delisted | Buy (P) | +200,000 | $799.1K | EDGAR |
| 2014-12-03 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-28 | — | Mixed | −482,281 | -$24.11M | |
| 2014-01-21 | VIROPHARMA INC (VPHM) Delisted | Exer (M) | +79,126 | $686.2K | EDGAR |
| 2014-01-07 | VIROPHARMA INC (VPHM) Delisted | Exer (M) | +40,309 | $143.1K | EDGAR |
| 2013-12-20 | VIROPHARMA INC (VPHM) Delisted | Mixed | +248,500 | -$10.48M | EDGAR |
| 2013-06-24 | VNDA | Grant (A) | — | $0 | EDGAR |
| 2013-06-12 | VIROPHARMA INC (VPHM) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.